Does stage 4 PKD at age 35 mean kidney failure soon?

Question

Hello doctor,

My 35-year-old daughter has polycystic kidney disease (PKD), which she inherited from me, and her kidney function has been declining each year.

Over the past six months, her serum creatinine increased from 1.4 mg/dL to 2.1 mg/dL, and estimated glomerular filtration rate (eGFR) dropped to 28 mL/min/1.73 m², which her nephrologist says indicates she is approaching advanced chronic kidney disease (stage 4).

Imaging studies show dozens of cysts in both kidneys, with several cysts measuring more than 1.57 inches in diameter. The enlarged cysts are causing significant pressure and discomfort, leading to severe back pain.

She was treated with Tolvaptan for eight months, but it had to be discontinued because her serum sodium level increased to 152 milliequivalents per liter (mEq/L).

She also has poorly controlled high blood pressure despite taking Lisinopril and Amlodipine, with average readings around 155/95 millimeters of mercury (mmHg). In addition, she was recently found to have liver cysts, and ultrasound imaging showed several large cysts that may require drainage.

She has also experienced three urinary tract infections (UTIs) this year, which her nephrologist explained are common in polycystic kidney disease because bacteria can become trapped within the kidney cysts.

The most distressing part is that she hopes to have children, but doctors have warned that pregnancy with advanced PKD and reduced kidney function could be dangerous for both her and the baby.

We are very worried she may need dialysis soon, and are anxious about her eligibility and timing for a kidney transplant.

Could you please advise on:

What are the newest treatments available to slow the progression of polycystic kidney disease?
Are there emerging therapies beyond Tolvaptan?
Options for managing cyst-related pain and recurrent infections?
How are pregnancy risks evaluated in women with eGFR around 28 mL/min/1.73 m²?
When should transplant evaluation ideally begin?

We would deeply appreciate guidance on the most up-to-date treatment options and next steps.

Please suggest.

Thank you.

Answer 1

Hello,

Welcome to icliniq.com.

Thank you for reaching out.

I truly understand how frightening this must feel as a parent, watching your daughter go through this, especially knowing she inherited autosomal dominant polycystic kidney disease (ADPKD, an inherited condition in which fluid-filled cysts gradually grow in the kidneys, causing them to enlarge and slowly lose function over time) from you. Please know that while this is a serious condition, there is still room for careful management and planning.

An eGFR (estimated glomerular filtration rate)of 28 mL/min/1.73 m² places her in stage 4 chronic kidney disease (a long-term condition in which the kidneys gradually lose their ability to filter waste and excess fluid from the blood), which is advanced, but it does not mean dialysis (a medical treatment that removes waste, excess fluids, and toxins from the blood when the kidneys can no longer do so adequately) right now. Many patients remain stable at this stage for a period of time with strict monitoring and aggressive management.

Right now, the most important factor is blood pressure control. Readings around 155/95 mmHg are higher than ideal and can accelerate kidney decline. The target is usually closer to 120 to 130 mmHg systolic (if tolerated).

Her medications may need adjustment, dose optimization, or an additional agent under her nephrologist’s supervision. Tight blood pressure control is the single most powerful tool we have to slow progression.

Regarding Tolvaptan, it is currently the only approved medication shown to slow cyst growth in ADPKD. However, elevated sodium levels and dehydration are known side effects. If her sodium rose to unsafe levels, stopping it was the correct and responsible decision.

Large cysts causing severe back pain can sometimes be drained or treated with interventional procedures if symptoms are significant. Liver cysts are also common in ADPKD and usually do not impair liver function, though occasionally large ones may require treatment for comfort.

Recurrent urinary tract infections occur because bacteria can become trapped within cysts. Early diagnosis and prompt antibiotic treatment are essential to protect remaining kidney tissue.

With an eGFR of 28 (about 28 percent kidney function) and uncontrolled high blood pressure, pregnancy carries higher risks, including preeclampsia (a dangerous rise in blood pressure during pregnancy), worsening kidney function, and premature delivery (baby born too early). Careful planning and close specialist monitoring would be essential.

It is not impossible, but it must be very carefully planned with a nephrologist and a high-risk obstetric (maternal-fetal medicine) team. Blood pressure must be well controlled before attempting pregnancy.

If kidney function continues to decline, kidney transplantation is the best long-term treatment. The reassuring part is that patients with ADPKD generally do very well after transplant. Outcomes are often excellent because the disease does not recur in the transplanted kidney.

Beyond Tolvaptan, newer therapies are still under research, and current management focuses on:

Strict blood pressure control.
Low-salt diet.
Adequate hydration (unless sodium remains high).
Avoiding kidney-toxic medications (like NSAIDs or nonsteroidal anti-inflammatory drugs).
Early treatment of infections.
Maintaining a healthy weight.

Dialysis is typically needed when eGFR falls below about 10 to 15 mL/min/1.73 m² with symptoms. She is not there yet.

This is a progressive disease, but the rate of progression varies widely. With close follow-up, aggressive blood pressure management, and early transplant planning, she can still have a very good long-term outcome. You are right to plan ahead; that preparation makes a real difference.

I hope this helps.

Please revert in case of further queries.

Thank you.